However, testing of larger samples is necessary to confirm the sensitivity and specificity of serum CD155 in detecting HSIL and cervical cancer patients and the efficiency and feasibility of cervical cancer screening combined with conventional HPV DNA testing and cytology need to be further evaluated and verified. The gene discussed is PVR; the disease is cervical carcinoma.